INTRODUCTION
Persistent ductus arteriosus (PDA) increases the risk of complications and worsens the prognosis of premature infants (1) . Therefore early closure of PDA is usually reccomended. Indomethacin (IND), an inhibitor of prostaglandin synthesis, is widely used for closing symptomatic PDA in premature infants (2) .
IND has cardiovascular effects such as causing cardiac diastolic dysfunction in the premature infants (3) . The negative effects of IND on cardiac function might be clinically significant in association with increased cardiac demand as evidenced for example by ST segment depression in the ECG of premature infants with PDA and respiratory distress syndrome (4) . Its hemodynamic side effects such as reduction of blood flow to the brain, intestinal organs and kidneys, are well known (5) (6) (7) (8) . However, the effect of IND on coronary flow with clinically used doses is poorly documented. The aim of the study was to investigate the effects of clinical doses of 0.2 mg/kg of IND on coronary blood flow by using an Intracoronary Doppler Guide Wire (IDGW) in a premature newborn lamb model.
MATERIAL AND METHOD
Nine premature newborn lambs of mixed breed and gender were studied during the first day of life. Their gestational age varied between 132 and 134 days (term 145 days) and weight 3-4.7 kg (median 3.9 kg). The investigation conformed with the Guide for the Care and Use of Laboratory Animals and accepted by the Ethical committee, University of Lund, Sweden.
Animals.
Pregnant ewes were premedicated with xylazine 6-8 mg i.m. before transportation to the laboratory. After sedation with ketamine 35 mg i.v. thiopental 650-800 mg was injected i.v. The trachea was intubated and anaesthesia maintained with isoflurane in nitrousoxid/oxygen. The lungs were ventilated with a Servo ventilator keeping the end-tidal pCO 2 at 4.5-6 kPa. A single bolus dose of IND 0,2 mg/kg (0,4 ml/kg) was given over 1 minute i.v.
(2). The flow velocity was registered continuously until the flow returned to its preinjection level. Recovery time was defined as time between lowest APV after indomethacin injection until the APV had returned to the preinjection level.
Arterial pressure was measured with pressure transducers, using the midchest level as the zero reference. Heart rate was obtained via a continuous ECG monitoring. Blood gas tensions, pH and Hb were measured with a Radiometer OSM 3 blood gas analyzer (Radiometer Copenhagen). SpO 2 was additionally monitored continuously by a pulse-oxymeter. After completing the experimental protocol the lambs were killed with an overdose of thiopenthal
Statistical analysis
Paired sample t-test was used to test the effect of indomethacin on blood pressure and heart rate. A simple regression analysis was used to find a correlation coefficient (r) between coronary flow velocity before and after IND, and the correlation between maximum lowering of flow velocity and recovery time. P-value < 0.05 was considered significant.
RESULTS
IND administration led to decrease in heart rate and cardiac output while blood pressure and rate pressure product (RPP) increased significantly (Table 1) Some centres, such as Lund, have changed the treatment regime to ibuprofen.
However, one study on dogs showed reduced flow in coronary collaterals after ibuprofen injection (20) . Other studies suggest that ibuprofen has less influence on flow and perfusion of organs as compared to IND. Ibuprofen seems to have no negative effect on cerebral, mesenteric and renal blood flow (21, 22, 23) , but the effect on the PDA seems to be comparable (24, 25) . More information about ibuprofens effect on coronary flow is needed.
The limitations of our study are that we don't have any documentation of myocardial perfusion and performance during administration of IND. Moreover, we did not have techniques to measure diameter of the coronary arteries during IND delivery. Per cent lowering of flow velocity
